Increased rheumatoid factor interference observed during immunogenicity assessment of an Fc-engineered therapeutic antibody
Authors:
- Marcel ZocherMZMarcel Zocher
- Kristin WallaceKWKristin Wallace
- Kun PengKPKun Peng
- Saloumeh Kadkhodayan FischerSFSaloumeh Kadkhodayan Fischer
- 1 July 2011
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 55 (5) , 1041-1049
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Therapeutic antibodies for autoimmunity and inflammationNature Reviews Immunology, 2010
- A Therapeutic Anti–VEGF Antibody with Increased Potency Independent of Pharmacokinetic Half-lifeCancer Research, 2010
- Pharmacokinetics of Humanized Monoclonal Anti-Tumor Necrosis Factor-α Antibody and Its Neonatal Fc Receptor Variants in Mice and Cynomolgus MonkeysDrug Metabolism and Disposition, 2010
- Functional Characterization of N297A, A Murine Surrogate for low-Fc Binding Anti-Human CD3 AntibodiesImmunological Investigations, 2009
- Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology productsJournal of Pharmaceutical and Biomedical Analysis, 2008
- Anti-IgE monoclonal antibody, omalizumab: a new treatment for allergic asthmaExpert Opinion on Pharmacotherapy, 2004
- Pathogenetic concepts and origins of rheumatoid factor in rheumatoid arthritisArthritis & Rheumatism, 1993
- Monoreactive and Polyreactive Rheumatoid Factors Produced by in Vitro Epstein-Barr Virus-Transformed Peripheral Blood and Synovial B Lymphocytes from Rheumatoid Arthritis PatientsScandinavian Journal of Immunology, 1990
- Monoreactive high affinity and polyreactive low affinity rheumatoid factors are produced by CD5+ B cells from patients with rheumatoid arthritis.Journal of Experimental Medicine, 1988
- IgM, IgA and IgG rheumatoid factors in patients with rheumatoid arthritis and normal donorsClinical Rheumatology, 1985